Child–Adult Transition in Sarcoidosis: A Series of 52 Patients
Authors:
- Simon ChauveauSCSimon Chauveau
- Florence JenyFJFlorence Jeny
- Marie-Emeline MontagneMMMarie-Emeline Montagne
- Rola Abou TaamRTRola Abou Taam
- Véronique HoudouinVHVéronique Houdouin
- Ulrich MeinzerUMUlrich Meinzer
- Christophe DelacourtCDChristophe Delacourt
- Ralph EpaudRERalph Epaud
- Fleur Cohen AubartFAFleur Cohen Aubart
- Catherine Chapelon-AbricCCCatherine Chapelon-Abric
- Dominique Israël-BietDIDominique Israël-Biet
- Karine JuvinKJKarine Juvin
Open Access
- 3 July 2020
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (7) , 2097
Abstract
(1) Background: Pediatric sarcoidosis is a rare and mostly severe disease. Very few pediatric series with a prolonged follow-up are reported. We aimed to evaluate the evolution of pediatric sarcoidosis in adulthood. (2) Material and methods: Patients over 18-years-old with a pediatric-onset sarcoidosis (≤15-year-old) who completed at least a three-year follow-up in French expert centers were included. Clinical information at presentation and outcome in adulthood were studied. (3) Results: A total of 52 patients were included (34 prospectively in childhood and 18 retrospectively in adulthood), with a mean age of 12 (±2.7) at diagnosis. The median duration time of follow-up was 11.5 years (range 3–44.5). Relapses mostly occurred during treatment decrease (84.5%), others within the three years after treatment interruption (9.1%), and rarely when the disease was stable for more than three years (6.4%). Sarcoidosis was severe in 11 (21.2%) in adulthood. Patients received a high corticosteroid cumulative dose (median 17,900 mg) for a median duration of five years (range 0–32), resulting in mostly mild (18; 35.3%) and rarely severe (2; 3.8%) adverse events. (4) Conclusions: Pediatric-onset sarcoidosis needed a long-term treatment in almost half of the patients. Around one fifth of pediatric-onset sarcoidosis patients had severe sarcoidosis consequences in adulthood.Keywords
This publication has 31 references indexed in Scilit:
- A national internet-linked based database for pediatric interstitial lung diseases: the French networkOrphanet Journal of Rare Diseases, 2012
- Paediatric Interstitial Lung Disease: Classification and DefinitionsPaediatric Respiratory Reviews, 2011
- Stage IV sarcoidosis: comparison of survival with the general population and causes of deathEuropean Respiratory Journal, 2011
- Health-related quality of life in adult survivors of childhood sarcoidosisRespiratory Medicine, 2009
- Childhood sarcoidosis: A rare but fascinating disorderPediatric Rheumatology, 2008
- Diffuse Lung Disease in Young ChildrenAmerican Journal of Respiratory and Critical Care Medicine, 2007
- SarcoidosisNew England Journal of Medicine, 2007
- Sarcoidosis in childrenCurrent Problems in Pediatrics, 2000
- ATS/ERS/WASOG statement on sarcoidosisEuropean Respiratory Journal, 1999
- Course and prognosis of sarcoidosis in a nonreferral setting. Analysis of 86 patients observed for 10 yearsThe American Journal of Medicine, 1985